Hajo M Hamer1, Karel Kostev. 1. Department of Neurology, Epilepsy Center, University of Erlangen, Schwabachanlage 6, 91054, Erlangen, Germany, hajo.hamer@uk-erlangen.de.
Abstract
BACKGROUND: Large epidemiological databases facilitate the study of medical care in different subgroups of the population and how such care compares with standard treatment guidelines. This study aimed for such analyses regarding utilization of antiepileptic drugs (AEDs) for epilepsy in Germany. METHOD: The data source was the Disease Analyzer(®) database that is representative for the German population and assembles anonymous demographic and medical (diagnoses, prescriptions) data obtained from the practice computer system of general practitioners and specialists throughout Germany. A total of 43,712 adult patients with an epilepsy diagnosis (International Classification of Diseases, 10th edition [ICD10] code: G40.X) seen in 2010-2012 by 346 neurologists were retrospectively analysed according to sociodemographic characteristics, comorbidity, and AED treatment. Multivariate logistic regression was applied to calculate adjusted odds ratios (ORs) with 95 % confidence intervals (CIs). RESULTS: As compared with women, men were less likely to receive lamotrigine (OR 0.68; 95 % CI 0.65-0.72; p < 0.001) and were treated preferably with carbamazepine (OR 1.29; 95 % CI 1.23-1.35; p < 0.001). As compared with patients covered by private health insurance (PHI), patients with statutory health insurance (SHI) were treated more often with valproate (OR 1.19; 95 % CI 1.07-1.31; p < 0.001) and showed a higher rate of obesity (SHI: 3.1 %; PHI: 1.6 %; p < 0.001), while PHI was associated with administration of levetiracetam (OR 1.27; 95 % CI 1.16-1.4; p < 0.001). Carbamazepine (OR 1.25; 95 % CI 1.17-1.31; p < 0.001) and primidone (OR 1.23; 95 % CI 1.08-1.38; p < 0.001) were administered to a larger extent in rural versus urban areas. Lamotrigine (OR 1.31; 95 % CI 1.23-1.39; p < 0.001) was used more often in West than in East Germany. Living in an urban community raised the likelihood of being treated with levetiracetam (OR 1.23; 95 % CI 1.17-1.28; p < 0.001). CONCLUSIONS: In spite of common guidelines, AED treatment differed significantly among adults with epilepsy in Germany. Besides gender, type of health insurance and place of residence strongly influenced AED administration.
BACKGROUND: Large epidemiological databases facilitate the study of medical care in different subgroups of the population and how such care compares with standard treatment guidelines. This study aimed for such analyses regarding utilization of antiepileptic drugs (AEDs) for epilepsy in Germany. METHOD: The data source was the Disease Analyzer(®) database that is representative for the German population and assembles anonymous demographic and medical (diagnoses, prescriptions) data obtained from the practice computer system of general practitioners and specialists throughout Germany. A total of 43,712 adult patients with an epilepsy diagnosis (International Classification of Diseases, 10th edition [ICD10] code: G40.X) seen in 2010-2012 by 346 neurologists were retrospectively analysed according to sociodemographic characteristics, comorbidity, and AED treatment. Multivariate logistic regression was applied to calculate adjusted odds ratios (ORs) with 95 % confidence intervals (CIs). RESULTS: As compared with women, men were less likely to receive lamotrigine (OR 0.68; 95 % CI 0.65-0.72; p < 0.001) and were treated preferably with carbamazepine (OR 1.29; 95 % CI 1.23-1.35; p < 0.001). As compared with patients covered by private health insurance (PHI), patients with statutory health insurance (SHI) were treated more often with valproate (OR 1.19; 95 % CI 1.07-1.31; p < 0.001) and showed a higher rate of obesity (SHI: 3.1 %; PHI: 1.6 %; p < 0.001), while PHI was associated with administration of levetiracetam (OR 1.27; 95 % CI 1.16-1.4; p < 0.001). Carbamazepine (OR 1.25; 95 % CI 1.17-1.31; p < 0.001) and primidone (OR 1.23; 95 % CI 1.08-1.38; p < 0.001) were administered to a larger extent in rural versus urban areas. Lamotrigine (OR 1.31; 95 % CI 1.23-1.39; p < 0.001) was used more often in West than in East Germany. Living in an urban community raised the likelihood of being treated with levetiracetam (OR 1.23; 95 % CI 1.17-1.28; p < 0.001). CONCLUSIONS: In spite of common guidelines, AED treatment differed significantly among adults with epilepsy in Germany. Besides gender, type of health insurance and place of residence strongly influenced AED administration.
Authors: E Wayne Holden; Elizabeth Grossman; Hoang Thanh Nguyen; Margaret J Gunter; Becky Grebosky; Ann Von Worley; Leila Nelson; Scott Robinson; David J Thurman Journal: Dis Manag Date: 2005-02
Authors: Torbjörn Tomson; Dina Battino; Erminio Bonizzoni; John Craig; Dick Lindhout; Anne Sabers; Emilio Perucca; Frank Vajda Journal: Lancet Neurol Date: 2011-06-05 Impact factor: 44.182
Authors: Charles E Begley; Rituparna Basu; Thomas Reynolds; David R Lairson; Stephanie Dubinsky; Michael Newmark; Forbes Barnwell; Allen Hauser; Dale Hesdorffer; Nora Hernandez; Steven C Karceski; Tina Shih Journal: Epilepsia Date: 2008-11-17 Impact factor: 5.864
Authors: Ana-Claire L Meyer; Tarun Dua; W John Boscardin; José J Escarce; Shekhar Saxena; Gretchen L Birbeck Journal: Epilepsia Date: 2012-10-25 Impact factor: 5.864
Authors: Anthony G Marson; Asya M Al-Kharusi; Muna Alwaidh; Richard Appleton; Gus A Baker; David W Chadwick; Celia Cramp; Oliver C Cockerell; Paul N Cooper; Julie Doughty; Barbara Eaton; Carrol Gamble; Peter J Goulding; Stephen J L Howell; Adrian Hughes; Margaret Jackson; Ann Jacoby; Mark Kellett; Geoffrey R Lawson; John Paul Leach; Paola Nicolaides; Richard Roberts; Phil Shackley; Jing Shen; David F Smith; Philip E M Smith; Catrin Tudur Smith; Alessandra Vanoli; Paula R Williamson Journal: Lancet Date: 2007-03-24 Impact factor: 79.321
Authors: Samuel Waller Terman; Wesley T Kerr; Carole E Aubert; Chloe E Hill; Zachary A Marcum; James F Burke Journal: Neurology Date: 2021-12-10 Impact factor: 9.910
Authors: Gregor Feldmeier; Christin Löffler; Attila Altiner; Anja Wollny; Felix von Podewils; Manuela Ritzke Journal: Pilot Feasibility Stud Date: 2022-09-21